Minnesota 2023-2024 Regular Session

Minnesota House Bill HF5428

Introduced
4/29/24  

Caption

Commissioner of human services directed to provide an annual report on treatments for sickle cell disease.

Impact

The bill will establish a formal process for the ongoing evaluation of sickle cell disease treatments and their effectiveness, which could lead to improved health outcomes for individuals facing this chronic condition. By requiring the commissioner to incorporate public input, particularly from those with experience in sickle cell treatment, the bill encourages a more inclusive and responsive healthcare policy approach. Furthermore, the mandate to report findings annually ensures that lawmakers and the public remain informed about the evolving landscape of treatment options, potentially influencing future legislative decisions regarding healthcare funding and policy.

Summary

House File 5428, introduced by Representative Noor, seeks to enhance the understanding and management of sickle cell disease in Minnesota through a systematic annual review process mandated by the state. The bill directs the Commissioner of Human Services to conduct an evaluation of the medications, treatments, and services available for individuals diagnosed with sickle cell disease who are enrolled in the state's medical assistance program. This annual review aims to assess whether current options meet the needs of affected enrollees and to identify if additional treatments should be incorporated into the coverage offered by the state.

Contention

While the bill generally aims to improve care for individuals with sickle cell disease, points of contention may arise regarding the adequacy of the state’s commitment to implementing these recommendations. Critics may question the effectiveness of merely producing annual reports without accompanying actions to ensure timely implementation of treatment enhancements. Additionally, there may be concerns about budgetary implications, especially if new treatments require increased funding from the state’s healthcare budget, emphasizing the balance between addressing public health needs and fiscal responsibility.

Companion Bills

MN SF5492

Similar To Sickle cell disease annual report on treatments by the Commissioner of Human services direction provisions

Previously Filed As

MN SF5492

Sickle cell disease annual report on treatments by the Commissioner of Human services direction provisions

MN HB820

Sickle cell disease; annual review of medication and treatment, report.

MN HB2084

Sickle cell disease; annual review of medication and treatment, report.

MN SB298

Requires the Louisiana Department of Health to annually review medications, forms of treatment, and services for care of Medicaid enrollees with sickle cell disease. (8/1/22)

MN HB2723

Sickle cell disease; annual review

MN H1085

Sickle Cell Disease

MN SB276

AN ACT relating to Medicaid coverage for sickle cell disease.

MN HB2927

Relating to sickle cell disease.

MN HB2338

Designating sickle cell disease awareness week and requiring KDHE to study and report on topics related to sickle cell disease.

MN AB1105

Sickle cell disease.

Similar Bills

No similar bills found.